Milestone raises $8.4 million for dental sales drive:
This article was originally published in Clinica
Executive Summary
Milestone Scientific has received $8.4m in net proceeds from a public offering of shares and warrants. The Livingston, New Jersey-based company will use the funds to increase its sales force and launch new marketing and advertising campaigns. Milestone makes local anaesthetic delivery systems for the dental and medical markets, and is launching a new product, SafetyWand, an auto-retractor needle for dental anaesthesia.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.